Effect of intravitreal drugs on integrity of retinal layers
Phase 3
- Conditions
- Health Condition 1: H350- Background retinopathy and retinalvascular changes
- Registration Number
- CTRI/2019/03/018135
- Lead Sponsor
- Department of Ophthalmology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. All consecutive cases of Type 2 DM, between age group 40-65 years, attending Retina Clinic of Department of Ophthalmology, K.G.M.U., Lucknow
2. In asymmetrical involvement, the eye with more severe form of the disease will be included
Exclusion Criteria
1.Patients with any other ocular or systemic disease which can affect the retinal vasculature( Ischemic heart disease)
2. Previous intravitreal injection(s), ophthalmic surgical or laser interventions
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Restoration Of Outer And Inner Retinal Layers Following Intravitreal Bevacizumab AdministrationTimepoint: 6 months
- Secondary Outcome Measures
Name Time Method Restoration Of Outer ,Inner Retinal Layers And Ellipsoid Zone Following Intravitreal BevacizumabTimepoint: 6 MONTHS